[ESPR] QoQ Quarter Result on 31-Dec-2013 [#Q4]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
13-Mar-2014
Financial Year
2013
Quarter
31-Dec-2013 [#Q4]
Profit Trend
QoQ- -84.98%
YoY- -249.15%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -9,806 -9,238 -7,874 -9,689 -5,238 -6,921 -4,239 74.82%
Tax 164 18 16 47 168 112 803 -65.28%
NP -9,806 -9,238 -7,874 -9,689 -5,238 -6,921 -4,239 74.82%
Tax Rate - - - - - - - -
Total Cost 9,806 9,238 7,874 9,689 5,238 6,921 4,239 74.82%
Ratio Analysis
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
EPS -0.64 -0.60 -0.51 -0.63 -0.34 -0.47 -0.29 69.42%
EPS Diluted -0.64 -0.60 -0.51 -0.63 -0.34 -0.47 -0.29 69.42%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.